Made for big pharma
Deccan Chronicle - 11/18/2014
Certain US experts have pointed out that the American administration consistently uses trade working groups to push for more severe patenting regimes that favour Big Pharma. Professor Brook Baker of the Northeastern University School of Law has cautioned that the working group would give the US a dedicated forum to continue to pressure India to adopt tougher patent protection measures. Jamie Love of NGO Knowledge Ecology International believes India would be under pressure to liberalise drug patents and to block or restrain the use of compulsory licensing.